+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Inotek Pharmaceuticals Corp (ITEK) - Financial and Strategic SWOT Analysis Review

  • ID: 4281576
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
  • Inotek Pharma
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Inotek Pharmaceuticals Corp (IPC) is a pharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of glaucoma and serious diseases of the eye. The company’s trabodenoson is a selective adenosine mimetic that stimulates a specific adenosine subreceptor. Its product pipeline include fixed dose combination that comprises trabodenoson plus latanoprost in an eye drop formulation. The company has three pharmacologic targets for intervention (adenosine, PARP, and reactive oxygen species including peroxynitrite), which regulates as cellular responses to tissue stress or injury. IPC is headquartered in Lexington, Massachusetts, the US.

Inotek Pharmaceuticals Corp Key Recent Developments

Aug 03, 2017: Inotek Pharmaceuticals Reports Second Quarter 2017 Financial Results and Operational Highlights
May 10, 2017: Inotek Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Highlights
Mar 16, 2017: Inotek Pharmaceuticals Reports Fiscal Year 2016 Financial Results and Operational Highlights

This comprehensive SWOT profile of Inotek Pharmaceuticals Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Inotek Pharmaceuticals Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Inotek Pharmaceuticals Corp - Key Information
  • Inotek Pharmaceuticals Corp - Overview
  • Inotek Pharmaceuticals Corp - Key Employees
  • Inotek Pharmaceuticals Corp - Key Employee Biographies
  • Inotek Pharmaceuticals Corp - Key Operational Heads
  • Inotek Pharmaceuticals Corp - Major Products and Services
  • Inotek Pharmaceuticals Corp - History
  • Inotek Pharmaceuticals Corp - Company Statement
  • Inotek Pharmaceuticals Corp - Locations And Subsidiaries
  • Inotek Pharmaceuticals Corp - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Inotek Pharmaceuticals Corp - Business Description
  • Inotek Pharmaceuticals Corp - Corporate Strategy
  • Inotek Pharmaceuticals Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Inotek Pharmaceuticals Corp - Strengths
  • Inotek Pharmaceuticals Corp - Weaknesses
  • Inotek Pharmaceuticals Corp - Opportunities
  • Inotek Pharmaceuticals Corp - Threats
  • Inotek Pharmaceuticals Corp - Key Competitors
Section 3 - Company Financial Performance Charts
  • Inotek Pharmaceuticals Corp - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Inotek Pharmaceuticals Corp, Key Information
  • Inotek Pharmaceuticals Corp, Key Ratios
  • Inotek Pharmaceuticals Corp, Share Data
  • Inotek Pharmaceuticals Corp, Major Products and Services
  • Inotek Pharmaceuticals Corp, History
  • Inotek Pharmaceuticals Corp, Key Employees
  • Inotek Pharmaceuticals Corp, Key Employee Biographies
  • Inotek Pharmaceuticals Corp, Key Operational Heads
  • Inotek Pharmaceuticals Corp, Other Locations
  • Inotek Pharmaceuticals Corp, Subsidiaries
  • Inotek Pharmaceuticals Corp, Key Manufacturing facilities
  • Inotek Pharmaceuticals Corp, Key Competitors
  • Inotek Pharmaceuticals Corp, SWOT Analysis
  • Inotek Pharmaceuticals Corp, Ratios based on current share price
  • Inotek Pharmaceuticals Corp, Annual Ratios
  • Inotek Pharmaceuticals Corp, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Inotek Pharmaceuticals Corp, Performance Chart
  • Inotek Pharmaceuticals Corp, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3